WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating...

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Gallbladder cancer (GBC) is a significant cause of cancer mortality globally.
• The tumor suppressor gene WW domain-containing oxidoreductase (WWOX) is known to inhibit various tumor types.
• The specific role of WWOX in gallbladder cancer remains largely unexplored.

Purpose of the Study:

• To investigate the tumor-suppressive function of WWOX in gallbladder cancer cells.
• To elucidate the underlying molecular mechanisms of WWOX's anti-cancer activity.
• To evaluate the therapeutic potential of WWOX in gallbladder cancer models.

Main Methods:

• In vitro studies involving gallbladder cancer cell lines.
• In vivo experiments using a mouse model of gallbladder cancer.
• Analysis of apoptosis-related gene expression (P73, PUMA, Bax, Bcl-2).
• Assessment of tumor proliferation and prognosis in mouse models.

Main Results:

• WWOX overexpression induced apoptosis in gallbladder cancer cells.
• WWOX modulated the expression of key apoptosis regulators: P73, PUMA, Bax, and Bcl-2.
• In vivo delivery of WWOX inhibited tumor proliferation and improved prognosis in mice.
• Upregulation of P73 and PUMA was observed in target tissues following WWOX administration.

Conclusions:

• WWOX exhibits significant tumor-suppressive effects in gallbladder cancer.
• WWOX exerts its function by promoting apoptosis and regulating key molecular pathways.
• WWOX demonstrates potential as a novel therapeutic agent for gene therapy in gallbladder cancer.